Skip to main content
. 2012 Dec 27;2012:529151. doi: 10.1100/2012/529151

Figure 4.

Figure 4

Sorafenib prolongs survival in Rip1Tag2 mice. Kaplan-Meier curve and log rank-analysis of Rip1Tag2 mice treated with Sorafenib or mock treatment. Note the significant increased survival in mice treated with Sorafenib (137.7 ± 17.8 d versus 102.8 ± 4.2 d; P = 0.032 log rank test).